Literature DB >> 25723469

miR-203 protects microglia mediated brain injury by regulating inflammatory responses via feedback to MyD88 in ischemia.

Zhao Yang1, Lina Zhong1, Shanchuan Zhong1, Ronghua Xian2, Bangqing Yuan3.   

Abstract

Much evidence demonstrates that microglia mediated inflammatory responses play an important role in brain injury in ischemia. miRNA is the important factor in regulation of inflammation. However, the effect of miRNA in microglia mediated inflammatory responses has not been well studied. In the study, we demonstrate that miR-203 negatively regulates ischemia induced microglia activation by targeting MyD88, an important adapter protein involved in most Toll-like receptors (TLRs) and interleukin-1 receptor (IL-1R) pathways. Through negative feedback, enforced expression of miR-203 or MyD88 siRNA silencing inhibits downstream NF-κβ signaling and microglia activation, thereby alleviating neuronal injury. These findings reveal that miR-203 represents a novel target regulating neuroinflammation and brain injury, thus offering a new therapeutical strategy for cerebral hypoxic diseases.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Ischemia; Microglia; MyD88; miR-203

Mesh:

Substances:

Year:  2015        PMID: 25723469     DOI: 10.1016/j.molimm.2015.01.019

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  26 in total

Review 1.  The Emerging Role of Epigenetics in Cerebral Ischemia.

Authors:  Zhiping Hu; Bingwu Zhong; Jieqiong Tan; Chunli Chen; Qiang Lei; Liuwang Zeng
Journal:  Mol Neurobiol       Date:  2016-02-19       Impact factor: 5.590

Review 2.  Mechanisms of microglial activation in models of inflammation and hypoxia: Implications for chronic intermittent hypoxia.

Authors:  Elizabeth A Kiernan; Stephanie M C Smith; Gordon S Mitchell; Jyoti J Watters
Journal:  J Physiol       Date:  2016-03-15       Impact factor: 5.182

3.  MicroRNA miR-21 Decreases Post-stroke Brain Damage in Rodents.

Authors:  Mary S Lopez; Kahlilia C Morris-Blanco; Nancy Ly; Carly Maves; Robert J Dempsey; Raghu Vemuganti
Journal:  Transl Stroke Res       Date:  2021-11-18       Impact factor: 6.829

4.  MeCP2 loss-of-function dysregulates microRNAs regionally and disrupts excitatory/inhibitory synaptic transmission balance.

Authors:  Patricia M Horvath; Michelle K Piazza; Ege T Kavalali; Lisa M Monteggia
Journal:  Hippocampus       Date:  2022-07-19       Impact factor: 3.753

5.  Downregulated miR-203 attenuates IL-β, IL-6, and TNF-α activation in TRAF6-treated human renal mesangial and tubular epithelial cells.

Authors:  Li Zhang; Xingkun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

6.  Dysregulated microRNA expression in IL-4 transgenic mice, an animal model of atopic dermatitis.

Authors:  Lei Bao; Cecilia S Chau; Zhengdeng Lei; Hong Hu; Angelina G Chan; Kyle T Amber; Mark Maienschein-Cline; Maria M Tsoukas
Journal:  Arch Dermatol Res       Date:  2021-01-12       Impact factor: 3.017

7.  The microRNA miR-21 conditions the brain to protect against ischemic and traumatic injuries.

Authors:  Mary S Lopez; Robert J Dempsey; Raghu Vemuganti
Journal:  Cond Med       Date:  2017-12-15

8.  miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1.

Authors:  Yi Zhang; Shu-yan Zhou; Hai-zhao Yan; Dan-dan Xu; Hai-xuan Chen; Xiao-yan Wang; Xiao Wang; Yu-ting Liu; Li Zhang; Sheng Wang; Peng-jun Zhou; Wu-yu Fu; Bi-bo Ruan; Dong-lei Ma; Ying Wang; Qiu-ying Liu; Zhe Ren; Zhong Liu; Rong Zhang; Yi-fei Wang
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

Review 9.  Epigenetic Modulators of Monocytic Function: Implication for Steady State and Disease in the CNS.

Authors:  F Nina Papavasiliou; Young Cheul Chung; Khatuna Gagnidze; Kaitlyn H Hajdarovic; Dan C Cole; Karen Bulloch
Journal:  Front Immunol       Date:  2016-01-15       Impact factor: 7.561

10.  miR-203 Expression in Exfoliated Cells of Tongue Coating Represents a Sensitive and Specific Biomarker of Gastroesophageal Reflux Disease.

Authors:  Xiuli Yan; Shengliang Zhu; Hui Zhang
Journal:  Gastroenterol Res Pract       Date:  2016-09-07       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.